Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Hamada

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|October 31, 2002
Pyothorax-associated lymphomaMasaki Yasukawa, Makoto Hamada, Koichi Ohshima
Leukemia & Lymphoma|June 30, 2004
The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphomaYoshihiro Yakushijin, Makoto Hamada, Masaki Yasukawa
Organic Letters|September 22, 2009
Efficient total synthesis of (-)-kaitocephalinMakoto Hamada, Tetsuro Shinada, Yasufumi Ohfune
Organic Letters|September 9, 2005
Total synthesis of (-)-kaitocephalinMasanori Kawasaki, Tetsuro Shinada, Makoto Hamada, et al.
British Journal of Haematology|April 29, 2003
Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphomaMakoto Hamada, Yoshihiro Yakushijin, Masaki Ohtsuka, et al.
British Journal of Haematology|November 4, 2004
Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significanceMasaki Otsuka, Yoshihiro Yakushijin, Makoto Hamada, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2020
Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-<i>α</i> StabilizationHiroki Takano, Jun-Ichi Yamaguchi, Sota Kato, et al.
The Journal of Dermatology|December 6, 2019
Clinical features and treatment of epidermal growth factor inhibitor-related late-phase papulopustular rashMikiko Tohyama, Makoto Hamada, Daijiro Harada, et al.
The Journal of Biological Chemistry|October 19, 2012
The structure of (-)-kaitocephalin bound to the ligand binding domain of the (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/glutamate receptor, GluA2Ahmed H Ahmed, Makoto Hamada, Tetsuro Shinada, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2016
Structure-activity relationship study at C9 position of kaitocephalinYoko Yasuno, Makoto Hamada, Yuya Yoshida, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|October 31, 2002
Pyothorax-associated lymphomaMasaki Yasukawa, Makoto Hamada, Koichi Ohshima
Leukemia & Lymphoma|June 30, 2004
The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphomaYoshihiro Yakushijin, Makoto Hamada, Masaki Yasukawa
Organic Letters|September 22, 2009
Efficient total synthesis of (-)-kaitocephalinMakoto Hamada, Tetsuro Shinada, Yasufumi Ohfune
Organic Letters|September 9, 2005
Total synthesis of (-)-kaitocephalinMasanori Kawasaki, Tetsuro Shinada, Makoto Hamada, et al.
British Journal of Haematology|April 29, 2003
Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphomaMakoto Hamada, Yoshihiro Yakushijin, Masaki Ohtsuka, et al.
British Journal of Haematology|November 4, 2004
Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significanceMasaki Otsuka, Yoshihiro Yakushijin, Makoto Hamada, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2020
Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-<i>α</i> StabilizationHiroki Takano, Jun-Ichi Yamaguchi, Sota Kato, et al.
The Journal of Dermatology|December 6, 2019
Clinical features and treatment of epidermal growth factor inhibitor-related late-phase papulopustular rashMikiko Tohyama, Makoto Hamada, Daijiro Harada, et al.
The Journal of Biological Chemistry|October 19, 2012
The structure of (-)-kaitocephalin bound to the ligand binding domain of the (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/glutamate receptor, GluA2Ahmed H Ahmed, Makoto Hamada, Tetsuro Shinada, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2016
Structure-activity relationship study at C9 position of kaitocephalinYoko Yasuno, Makoto Hamada, Yuya Yoshida, et al.
Pageof 2